IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Critical Reviews in Oncology/Hematology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

5.97

h-Index

2024-2025

 153

Rank

2024-2025

 1712

SJR

2024-2025

 1.82

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Critical Reviews in Oncology/Hematology
Abbreviation Crit. Rev. Oncol./Hematol.
Publication Type Journal
Subject Area, Categories, Scope Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1)
h-index 153
Overall Rank/Ranking 1712
SCImago Journal Rank (SJR) 1.82
Impact Score 5.97
Publisher Elsevier Ireland Ltd
Country Ireland
ISSN 10408428, 18790461
Best Quartile Q1
Coverage History 1983-2025




Aim and Scope


Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology, and reviews and original research articles in the field of geriatric oncology. Most of the reviews are written on invitation. All reviews and original research articles are subject to peer review before final acceptance.Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor, and to indicate the deadline by which they expect to submit their final manuscript. Authors of original research articles are requested to submit their manuscripts directly to the Editor.


About Critical Reviews in Oncology/Hematology


Critical Reviews in Oncology/Hematology is a journal covering the technologies/fields/categories related to Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1). It is published by Elsevier Ireland Ltd. The overall rank of Critical Reviews in Oncology/Hematology is 1712. According to SCImago Journal Rank (SJR), this journal is ranked 1.82. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 153. The best quartile for this journal is Q1.

The ISSN of Critical Reviews in Oncology/Hematology journal is 10408428, 18790461. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Critical Reviews in Oncology/Hematology is cited by a total of 3804 articles during the last 3 years (Preceding 2024).


Critical Reviews in Oncology/Hematology Impact IF 2024-2025


The Impact IF 2024 of Critical Reviews in Oncology/Hematology is 5.97, which is computed in 2025 as per its definition. Critical Reviews in Oncology/Hematology IF is increased by a factor of 0.39 and approximate percentage change is 6.99% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Critical Reviews in Oncology/Hematology Impact IF 2025 Prediction


Impact IF 2024 of Critical Reviews in Oncology/Hematology is 5.97. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Critical Reviews in Oncology/Hematology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 5.97
2023 5.58
2022 5.85
2021 6.30
2020 5.74
2019 6.19
2018 5.58
2017 4.93
2016 5.37
2015 5.84
2014 4.56

Critical Reviews in Oncology/Hematology h-index


  Table Setting

Critical Reviews in Oncology/Hematology has an h-index of 153. It means 153 articles of this journal have more than 153 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Critical Reviews in Oncology/Hematology ISSN


The ISSN of Critical Reviews in Oncology/Hematology is 10408428, 18790461. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Critical Reviews in Oncology/Hematology Rank and SCImago Journal Rank (SJR)


The overall rank of Critical Reviews in Oncology/Hematology is 1712. According to SCImago Journal Rank (SJR), this journal is ranked 1.82. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Critical Reviews in Oncology/Hematology by Year


Year SJR
2025/2026 Coming Soon
2024 1.82
2023 1.572
2022 1.510
2021 1.478
2020 2.084
2019 2.213
2018 1.791
2017 1.710
2016 1.988
2015 1.851
2014 1.863

Ranking of Critical Reviews in Oncology/Hematology by Year


Year Ranking
2025/2026 Coming Soon
2024 1712
2023 2083
2022 2110
2021 2141
2020 1224
2019 1102
2018 1655
2017 1807
2016 1414
2015 1674
2014 1595

Critical Reviews in Oncology/Hematology Publisher


Table Setting

Critical Reviews in Oncology/Hematology is published by Elsevier Ireland Ltd. It's publishing house is located in Ireland. Coverage history of this journal is as following: 1983-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Critical Reviews in Oncology/Hematology is Crit. Rev. Oncol./Hematol.. This abbreviation ('Crit. Rev. Oncol./Hematol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Critical Reviews in Oncology/Hematology


If your research field is/are related to Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Critical Reviews in Oncology/Hematology?

Critical Reviews in Oncology/Hematology latest impact IF is 5.97. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 6.30 (2021) and 4.56 (2014), respectively, in the last 11 years. Moreover, its average IS is 5.63 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology has an SJR (SCImago Journal Rank) of 1.82, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.213 in 2019 and the lowest being 1.478 in 2021. Furthermore, the average SJR of the Critical Reviews in Oncology/Hematology over the previous 11-year period stands at 5.63.


What's the latest h-index of the Critical Reviews in Oncology/Hematology?

The latest h-index of the Critical Reviews in Oncology/Hematology is 153.


Who's the publisher of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology is published by the Elsevier Ireland Ltd, with its country of publication being the Ireland.


What's the current ranking of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology is currently ranked 1712 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1102 in 2019 and its lowest position of 2141 in 2021.


What's the abbreviation or short name for the Critical Reviews in Oncology/Hematology?

The standard ISO4 abbreviation for the Critical Reviews in Oncology/Hematology is Crit. Rev. Oncol./Hematol..


Is the "Critical Reviews in Oncology/Hematology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Critical Reviews in Oncology/Hematology is classified as a journal that the Elsevier Ireland Ltd publishes.


What's the scope or major areas of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology encompasses the following areas:

  • Geriatrics and Gerontology
  • Hematology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology is assigned the following International Standard Serial Numbers (ISSN): 10408428, 18790461.


What's the best quartile of the Critical Reviews in Oncology/Hematology?

The best quartile for the Critical Reviews in Oncology/Hematology is Q1 (2024).


What's the coverage history of the Critical Reviews in Oncology/Hematology?

The Critical Reviews in Oncology/Hematology coverage history can be summarized as follows: 1983-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9811 Vilnius Gediminas Technical University 55 2.84
Zeitschrift fur Germanistische Linguistik journal 27452 Walter de Gruyter GmbH 17 0.29
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
CESifo Economic Studies journal 17776 Oxford University Press 36 0.89
International Journal of Mathematical Education in Science and Technology journal 6477 Taylor and Francis Ltd. 45 1.82
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Modern Language Journal journal 1033 Wiley-Blackwell 123 3.95
Studies in Continuing Education journal 4850 Routledge 44 3.35
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00

Check complete list




Year wise Impact Score (IS) of Critical Reviews in Oncology/Hematology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 5.97
2023 5.58
2022 5.85
2021 6.30
2020 5.74
2019 6.19
2018 5.58
2017 4.93
2016 5.37
2015 5.84
2014 4.56



Top Journals/Conferences in Geriatrics and Gerontology

Nature Aging
Springer | Germany

Lancet Healthy Longevity, The
Elsevier Ltd | United Kingdom

Alzheimer's and Dementia
John Wiley and Sons Inc | United States

Lancet Regional Health - Western Pacific, The
Elsevier Ltd | United Kingdom

Aging and Disease
International Society on Aging and Disease | United States

npj Aging
Nature Research | United Kingdom

Journals of Gerontology - Series B Psychological Sciences and Social Sciences
Gerontological Society of America | United States

Age and Ageing
Oxford University Press | United Kingdom

Journal of the American Geriatrics Society
Wiley-Blackwell Publishing Ltd | United Kingdom

Gerontologist, The
Gerontological Society of America | United States

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Blood
Elsevier B.V. | United States

Blood Cancer Journal
Springer Nature | United Kingdom

Lancet Haematology,The
Elsevier Ltd | United Kingdom

Blood cancer discovery
NLM (Medline) | United States

Leukemia
Springer Nature | United Kingdom

Experimental Hematology and Oncology
BioMed Central Ltd | United Kingdom

American Journal of Hematology
John Wiley and Sons Inc | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All